1h Free Analyst Time
The cardiovascular and soft tissue repair patches market is forecasted to grow by USD 1.98 billion during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the cardiovascular and soft tissue repair patches market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of mi, increasing investment by vendors for cardiovascular and soft tissue repair, and favorable reimbursement schemes.
The cardiovascular and soft tissue repair patches market is segmented as below:
By Application
- Soft tissue repair
- Cardiac repair
- Vascular repair
- Pericardial repair
- Dural repair
By Raw Material
- ePTFE
- Biomaterial and tissue engineered material
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cardiovascular and soft tissue repair patches market covers the following areas:
- Cardiovascular and soft tissue repair patches market sizing
- Cardiovascular and soft tissue repair patches market forecast
- Cardiovascular and soft tissue repair patches market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Raw Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cardiovascular and soft tissue repair patches market: Aegis Lifesciences Pvt. Ltd., Anteris Technologies Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Braile Biomedica, CorMatrix Inc., Edwards Lifesciences Corp., Glycar SA, Integra Lifesciences Corp., Labcor Laboratorios Ltda., LeMaitre Vascular Inc., Maverick Biosciences Pty Ltd., Shockwave Medical Inc., Tisgenx Inc., Vascudyne Inc., and W. L. Gore and Associates Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in diagnostic modalities."
According to the report, one of the major drivers for this market is the rising incidence of mi.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aegis Lifesciences Pvt. Ltd.
- Anteris Technologies Ltd.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Braile Biomedica
- CorMatrix Inc.
- Edwards Lifesciences Corp.
- Glycar SA
- Integra Lifesciences Corp.
- Labcor Laboratorios Ltda.
- LeMaitre Vascular Inc.
- Maverick Biosciences Pty Ltd.
- Shockwave Medical Inc.
- Tisgenx Inc.
- Vascudyne Inc.
- W. L. Gore and Associates Inc.
